Identifying novel allergens from a common indoor mould Aspergillus ochraceus

Sangeeta Roy1, Bodhisattwa Saha1, Swati Gupta Bhattacharya1

  • 1Division of Plant Biology, Bose Institute, 93/1 Acharya Prafulla Chandra Road, Kolkata 700009, India.

Journal of Proteomics
|February 24, 2021
PubMed

Insights

This study identifies ten allergenic proteins from the common indoor fungus Aspergillus ochraceus, including a major allergen, NADP(+)-dependent glycerol dehydrogenase (GldB). These findings offer new targets for treating fungal allergies and respiratory diseases in India.

Area of Science:

  • Allergy and Immunology
  • Mycology
  • Proteomics

Background:

  • Respiratory diseases and fungal sensitization are increasing concerns in India.
  • Common environmental fungi, like Aspergillus species, contribute significantly to allergic responses.
  • Aspergillus ochraceus, a prevalent indoor mold in India, has not been previously studied for its allergenic potential.

Purpose of the Study:

  • To investigate the allergenic potency of Aspergillus ochraceus mycelial proteins in an atopic patient cohort.
  • To identify novel IgE-binding proteins from Aspergillus ochraceus using an immunoproteomic approach.
  • To establish Aspergillus ochraceus as a causative agent of allergic responses in susceptible individuals.

Main Methods:

  • Utilized 1-D and 2-D IgE-specific western blotting to detect IgE-reactive proteins.
  • Employed MALDI-TOF/TOF and manual de novo peptide sequencing for protein identification.
  • Applied a homology-driven proteomics approach due to the unsequenced nature of Aspergillus ochraceus.

Main Results:

  • Identified ten cross-reactive IgE-binding proteins from Aspergillus ochraceus.
  • NAD P(+)-dependent glycerol dehydrogenase (GldB) homologous protein was identified as a major allergen.
  • Other identified proteins showed homology to known allergens like short-chain dehydrogenase and subtilisin-like serine protease.

Conclusions:

  • Aspergillus ochraceus is confirmed as a significant source of allergens contributing to allergic responses.
  • The identified IgE-binding proteins, including GldB, are potential candidates for developing hypoallergenic vaccines and immunotherapies for fungal allergy.
  • This study provides a foundation for further molecular characterization of allergens and development of targeted treatments for fungal-derived respiratory diseases.